AI
Wednesday, December 29, 2021 3:48:58 AM
Just a reminder - yesterday again a very high amount of 43.4% of the shares traded (and reported by FINRA) have been shorted and as a result, the shorts managed to keep the PPS down (as they did with an increase of short trading over the last few days). With all the facts and clarifications that we got in the latest Letter to Shareholders and the information nicely summarised in the fact sheet below (see link), it should just be a matter of time until Multikine will be approved by the FDA and the heavy manipulation by the shorts will come to an end after all those years they have been attacking Cel-Sci (it will be fun to see how they want to cover their 8.6 million shares
). I am so happy for all the cancer patients who will hopefully soon be able to profit from Multikine! GLTAL!! Daily Short Volume Ratio (fintel.io, FINRA)
2021-12-28 43.48%
2021-12-27 38.31%
2021-12-23 36.79%
2021-12-22 28.18%
https://cel-sci.com/wp-content/uploads/2021/07/CVM_FactSheet_website_072021.pdf
Recent CVM News
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM
